Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|August 21, 2019
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combinationSandra M Swain, Gong Tang, Peter C Lucas, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 27, 2019
Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1Christine M Gunn, Barbara G Bokhour, Victoria A Parker, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trialsHanna Bandos, Pedro A Torres-Saavedra, Eva Culakova, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|December 15, 2012
Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) TrialSuzanne C Danhauer, Claudine Legault, Hanna Bandos, et al.
Breast Cancer Research and Treatment|March 19, 2021
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)Laila A Gharzai, Lauren A Szczygiel, Dean A Shumway, et al.
Cancer|October 22, 2025
Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trialsGillian Gresham, N Lynn Henry, Hanna Bandos, et al.
Journal of the National Cancer Institute|September 28, 2017
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30Hanna Bandos, Joy Melnikow, Donna R Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete ResponseSandra M Swain, Gong Tang, Heather Ann Brauer, et al.
JNCI Cancer Spectrum|April 2, 2025
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trialHanna Bandos, Sungjin Kim, N Lynn Henry, et al.
Journal of the National Cancer Institute|May 15, 2023
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancerEleftherios P Mamounas, Hanna Bandos, Priya Rastogi, et al.
Pageof 4